New York State Common Retirement Fund Sells 2,198 Shares of RadNet, Inc. (NASDAQ:RDNT)

New York State Common Retirement Fund decreased its holdings in shares of RadNet, Inc. (NASDAQ:RDNT) by 1.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 115,598 shares of the medical research company’s stock after selling 2,198 shares during the period. New York State Common Retirement Fund’s holdings in RadNet were worth $8,073,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in RDNT. State Street Corp raised its stake in RadNet by 1.3% during the third quarter. State Street Corp now owns 2,446,179 shares of the medical research company’s stock valued at $169,740,000 after buying an additional 30,244 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of RadNet by 0.8% during the third quarter. Geode Capital Management LLC now owns 1,555,214 shares of the medical research company’s stock valued at $107,936,000 after acquiring an additional 11,613 shares in the last quarter. Principal Financial Group Inc. raised its position in shares of RadNet by 8.5% in the 3rd quarter. Principal Financial Group Inc. now owns 1,506,545 shares of the medical research company’s stock worth $104,539,000 after purchasing an additional 118,501 shares during the last quarter. JB Capital Partners LP raised its position in shares of RadNet by 15.9% in the 3rd quarter. JB Capital Partners LP now owns 1,504,061 shares of the medical research company’s stock worth $104,367,000 after purchasing an additional 206,850 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its stake in RadNet by 30.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,475,995 shares of the medical research company’s stock worth $103,532,000 after purchasing an additional 344,146 shares in the last quarter. 77.90% of the stock is currently owned by hedge funds and other institutional investors.

RadNet Price Performance

Shares of NASDAQ:RDNT opened at $59.67 on Wednesday. The firm has a market cap of $4.42 billion, a price-to-earnings ratio of -852.31 and a beta of 1.79. The firm has a fifty day moving average price of $66.64 and a 200 day moving average price of $69.22. RadNet, Inc. has a fifty-two week low of $36.47 and a fifty-two week high of $93.65. The company has a debt-to-equity ratio of 0.89, a quick ratio of 2.16 and a current ratio of 2.16.

Analyst Ratings Changes

Several equities research analysts recently weighed in on RDNT shares. Jefferies Financial Group reduced their price target on shares of RadNet from $100.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, January 15th. Truist Financial reiterated a “buy” rating and set a $88.00 target price (down from $94.00) on shares of RadNet in a research note on Wednesday, January 22nd. Finally, Barclays decreased their price target on RadNet from $85.00 to $74.00 and set an “overweight” rating for the company in a research note on Wednesday, January 22nd. One analyst has rated the stock with a sell rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $75.50.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.